Company Announcements

Notice of Results

14 February 2023

Investor Presentation

 LONDON, U.K. AND DALLAS, TX, U.S. - Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it will release its full year results for the year ended 31 December 2022 on Monday 27 February 2023.

Investor presentation

Wensheng Fan, Chief Executive Officer, and Nils Windler, Chief Financial Officer, will provide a live presentation relating to the full year results via the Investor Meet Company platform on Monday 27 February 2023 at 4.30 pm GMT.

The presentation is open to all existing and potential investors. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00 am GMT the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Spectral MD here.

Investors who already follow Spectral MD on the Investor Meet Company platform will automatically be invited.


For further information please contact:

Spectral MD Holdings, Ltd.

Wensheng Fan, Chief Executive Officer

via Walbrook PR

Nils Windler, Chief Financial Officer




SP Angel Corporate Finance LLP (NOMAD and Joint Broker)

Tel: +44 (0)20 3470 0470

Stuart Gledhill/Harry Davies-Ball (Corporate Finance)

Vadim Alexandre/Rob Rees (Sales & Broking)





Stifel Nicolaus Europe Limited (Joint Broker)

Charles Hoare / Ben Maddison / Nick Harland

Will Palmer-Brown

Tel: +44 (0)20 7710 7600



Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Louis Ashe-Jepson /

Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393

+44 (0)7407 804 654


About Spectral MD:                                                                                       

We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.

[email protected]